First Quantum Minerals Ltd. ("First Quantum" or the "Company") (TSX: FM) will release fourth quarter and year-end 2025 financial and operating results on Tuesday ...
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine in first line unfit acute myeloid leukemia PARIS, FRANCE, 13 JANUARY 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback